Redefining cardiometabolic aging.

Redefining cardiometabolic aging.

Zoe Biosciences is developing best-in-class therapies to treat cardiometabolic disease.

Zoe Biosciences is developing best-in-class therapies to treat cardiometabolic disease.

Introduction

We are built upon decades of combined PAI-1 and APJ research with target validation across preclinical and human epidemiological and epigenetic indices.

We are spread across California and Illinois.

Cardiometabolic disease is a defining challenge of our time.

At Zoe, we address cardiometabolic aging at its source.

32%

Of all global deaths

Are due to cardiovascular diseases

> 1/3

U.S. adults

Have prediabetes--most don't know they have it

Trillions

USD

Annual cost to the global economy

CVD kills more women globally than all forms of cancer combined

We are a team of drug discovery and translational experts